Search in:

Patient Preference and Adherence Volume 7, 2013 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Real world outcomes of adding rapid-acting insulin versus switching to analog premix insulin among US patients with type 2 diabetes treated with insulin glargine

Raymond Miao1 Sanofi US, Bridgewater, NJ, USACorrespondence[email protected]

Wenhui Wei1 Sanofi US, Bridgewater, NJ, USA

Onur Baser2 STATinMeD Research, Ann Arbor, MI, USA;3 Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA

Lin Xie2 STATinMeD Research, Ann Arbor, MI, USA

Pages 951-960 | Published online: 19 Sep 2013

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (12)

Elizabeth L. Eby, Neal R. Kelly, Jeffrey K. Hertzberg, Moira C. Blodgett, Callie Stubbins, Raja H. Patel, Eric S Meadows, Brian D. Benneyworth & Douglas E. Faries. (2022) Predicting Response to Bolus Insulin Therapy in Patients With Type 2 Diabetes. Journal of Diabetes Science and Technology, pages 193229682210980.
Crossref

Rajesh R. Mehta, Alison M. Edwards, Swapnil Rajpathak, Ajay Sharma, Kenneth J. Snow & Kristy Iglay. (2020) Effects of conformance to type 2 diabetes guidelines on health care resource utilization, clinical outcomes, and cost: A retrospective claims analysis. Journal of Clinical & Translational Endocrinology 19, pages 100215.
Crossref

Edward B. Jude, Mark Nixon, Caroline O’Leary, Melissa Myland, Nick Gooch, Alka Shaunik & Elisheva Lew. (2019) Evaluating Glycemic Control in Patients with Type 2 Diabetes Suboptimally Controlled on Basal Insulin: UK ATTAIN Real-World Study. Diabetes Therapy 10:5, pages 1847-1858.
Crossref

Bruno Guerci, Neha Chanan, Simarjeet Kaur, Juan Guillermo Jasso-Mosqueda & Elisheva Lew. (2019) Lack of Treatment Persistence and Treatment Nonadherence as Barriers to Glycaemic Control in Patients with Type 2 Diabetes. Diabetes Therapy 10:2, pages 437-449.
Crossref

Diana Brixner, Anastasia Ermakova, Yan Xiong, Ray Sieradzan, Naomi Sacks, Philip Cyr & Stephanie D. Taylor. (2019) Clinical and Economic Outcomes of Patients with Type 2 Diabetes on Multiple Daily Injections of Basal-bolus Insulin (MDI) Therapy: A Retrospective Cohort Study. Clinical Therapeutics 41:2, pages 303-313.e1.
Crossref

D. Raccah. (2017) Basal insulin treatment intensification in patients with type 2 diabetes mellitus: A comprehensive systematic review of current options. Diabetes & Metabolism 43:2, pages 110-124.
Crossref

Patrick N. Racsa, Yunus Meah, Jeffrey J. Ellis & Kimberly R. Saverno. (2017) Comparative Effectiveness of Rapid-Acting Insulins in Adults with Diabetes. Journal of Managed Care & Specialty Pharmacy 23:3, pages 291-298.
Crossref

Samuel StolpeMichel A. KroesNeil WebbTami Wisniewski. (2016) A Systematic Review of Insulin Adherence Measures in Patients with Diabetes. Journal of Managed Care & Specialty Pharmacy 22:11, pages 1224-1246.
Crossref

Ali A. Rizvi. (2016) Treatment of Type 2 Diabetes with Biphasic Insulin Analogues. EMJ Diabetes, pages 74-83.
Crossref

Tao Wang, Kenneth A. Conrad, Kate van Brunt & Tina M. Rees. (2016) Attributes Influencing Insulin Pen Preference Among Caregivers and Patients With Diabetes Who Require Greater Than 20 Units of Mealtime Insulin. Journal of Diabetes Science and Technology 10:4, pages 923-931.
Crossref

Dario Giugliano, Paolo Chiodini, Maria Ida Maiorino, Giuseppe Bellastella & Katherine Esposito. (2015) Intensification of insulin therapy with basal-bolus or premixed insulin regimens in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Endocrine 51:3, pages 417-428.
Crossref

P. Darmon & D. Raccah. (2015) Options for intensification of basal insulin in type 2 diabetes: Premeal insulin or short-acting GLP-1 receptor agonists?. Diabetes & Metabolism 41:6, pages 6S21-6S27.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Real world outcomes of adding rapid-acting insulin versus switching to analog premix insulin among US patients with type 2 diabetes treated with insulin glargine

Articles from other publishers (12)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Real world outcomes of adding rapid-acting insulin versus switching to analog premix insulin among US patients with type 2 diabetes treated with insulin glargine

Citations (12)

Articles from other publishers (12)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date